Literature DB >> 22579356

Reply to Santhanam Sundar's letter to the editor Re: Arnulf Stenzl, Nigel C. Cowan, Maria De Santis, et al. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol 2011;59:1009-18.

Arnulf Stenzl, Nigel C Cowan, Maria De Santis, Markus A Kuczyk, Axel S Merseburger, Maria José Ribal, Amir Sherif, J Alfred Witjes, Thierry Lebret.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22579356     DOI： 10.1016/j.eururo.2012.04.042

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  5 in total

1.  S-phase kinase-associated protein 2 impairs the inhibitory effects of miR-1236-3p on bladder tumors.

Authors:  Qingsong Zhang; Shuo Miao; Chuanchang Li; Kai Cui; Qiangqiang Ge; Zhong Chen
Journal:  Am J Transl Res       Date:  2018-03-15       Impact factor: 4.060

2.  The Inhibitory Effect of PDIA6 Downregulation on Bladder Cancer Cell Proliferation and Invasion.

Authors:  He-Peng Cheng; Qian Liu; Yang Li; Xiao-Dong Li; Chao-Yang Zhu
Journal:  Oncol Res       Date:  2016-10-18       Impact factor: 5.574

3.  Comparative analysis of the clinical effect and safety of Laparoscopic Radical Cystectomy + Orthotopic Ileal Neobladder and Open Surgery.

Authors:  Yuan-Hua Liu; Hai-Tao Dai; Chang-Mao Liu; Jiang Zheng
Journal:  Pak J Med Sci       Date:  2021 Jan-Feb       Impact factor: 1.088

4.  Enhancing E-cadherin expression via promoter-targeted miR-373 suppresses bladder cancer cells growth and metastasis.

Authors:  Qingsong Zhang; Chenghe Wang; Shuo Miao; Chuanchang Li; Zhong Chen; Fan Li
Journal:  Oncotarget       Date:  2017-09-30

5.  Transurethral holmium laser resection and transurethral electrocision combined with intravesical epirubicin within 24 hours postoperatively for treatment of bladder cancer.

Authors:  Jiawei Lu; Yagang Xue; Feng Shen; Hongxing Gu; Haiyong Liu; Jianhua Hou; Huidong Miao
Journal:  J Int Med Res       Date:  2019-12-29       Impact factor: 1.671
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.